Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients (Q35064406)

24325216

6 August 2017

title

Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients (English)

1 reference

6 August 2017

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Rune Andersson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Inger Johansson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Gunnar Mårtensson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ulla Nyström

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

1 reference

10 December 2013

1 reference

24325216

6 August 2017

published in

BMC Infectious Diseases

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

582

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

10 June 2020

copyright license

start time

1 December 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Bronchiolitis obliterans syndrome: the final frontier for lung transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Cytomegalovirus in transplantation - challenging the status quo.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in lung transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Definitions of cytomegalovirus infection and disease in transplant recipients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Infectious complications of lung transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878887

Cytomegalovirus and long-term outcome after lung transplantation in Gothenburg, Sweden.

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

An international survey of cytomegalovirus management practices in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

A multicenter study of valganciclovir prophylaxis up to day 120 in CMV-seropositive lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

Timing of basiliximab induction and development of acute rejection in lung transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-582

Analysis of risk factors for the development of bronchiolitis obliterans syndrome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24325216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bronchiolitis obliterans syndrome development in lung transplantation patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24325216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cytomegalovirus Replication Within the Lung Allograft Is Associated With Bronchiolitis Obliterans Syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24325216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-13-582

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

24325216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325216%20AND%20SRC:MED&resulttype=core&format=json